Clients with Renal Impairment Ritalin has not been examined in renally-impaired people. Renal impairment is predicted to own minimum effect on the pharmacokinetics of methylphenidate given that fewer than one% of the radiolabeled dose is excreted during the urine as unchanged compound, and the foremost metabolite (ritalinic acid), has little if any